Online Programme 2020


1 October 2020 | Park Plaza Victoria

09:00 - 10:00

Registration, networking and refreshments

09:45 - 10:00

Chair’s opening remarks

Ben Clover, Bureau Chief, HSJ

10:00 - 10:30

Keynote presentation:
National update: Progress on delivering the Long Term Plan for cancer

  • Diagnosing cancer earlier and personalising treatment
  • Building systems: Primary care Networks and Cancer Alliances
  • Innovating to meet the challenges

Professor Peter Johnson, National Clinical Director for Cancer, NHS England and NHS Improvement

10:30 - 11:05

Panel discussion:
Reducing the cancer burden: the role of public health messaging

  • Consider the importance of national public health campaigns vs local campaigns
  • Understand the roles of primary and acute care in prevention, screening and early diagnosis
  • Learn about the impact of campaigns, including on the demand for screening and the gap between more affluent and more deprived communities


Freya Howle, CURE Programme Lead, Greater Manchester Cancer

Barbara Rice, Team Leader and Operational Manager, Healthwatch Thurrock

Matthew Walmsley, Deputy Director - Marketing Strategy, Planning & Insight, Public Health England

11:05 – 11:20

Morning refreshments and networking

11:20 – 12:05

Interactive Discussion Groups

Join these focused small group discussions to share experiences with colleagues, learn from each other and get your pressing questions answered. With the number of participants per table limited, make sure you sign up early to ensure your place at your two preferred tables

Formation of the PCNs: impacts and opportunities Faster Diagnosis Standard: cascading best practice
Funding innovative work How primary care teams can support personalised care
Trials bring innovative treatments and Trust income. How can we do more?
Novartis Oncology
Ensuring patient centred care
Supporting local systems to deliver cell and gene therapy in cancer care
Mind the gap: managing workforce challenges

12:05 – 13:05

Lunch and networking

Breakout sessions

The following sessions give you the opportunity to go into more detail on key topics with presentations and discussions from experts and trailblazers. ‘Solution’ sessions take a closer look at current challenges and the practical strategies for addressing them. ‘Opportunity’ sessions take a forward-look at some of the most exciting innovations and ground-breaking work.


Stream A

Stream B

13:05 – 13:45

What the future holds for cancer treatments

  • Learn about innovative, new and future cancer treatments from those creating and commissioning them
  • Understand what you need to do now, in order to ensure you are ready for future treatments
  • Discuss how to reduce variations in access to the most effective treatments

Session reserved for Gilead

Practical strategies for doing the best with the capacity and workforce we have

  • Discover how to remove the barriers to networked working, including governance agreements and ways of sharing information
  • Understand the impact of multidisciplinary team meeting reform on efficiency and effectiveness and how to achieve this
  • Discuss recruitment and retention strategies for addressing the shortage of CNS

Jackie Fenemore, Chair, Lung Cancer Nursing UK

Chris Harrison, Medical Director, The Christie FT

David Long, Oncology Business Unit Director, MSD

John Renninson, Clinical Lead, Peninsula Cancer Alliance

13:45 – 13:50

Session change

13:50 – 14:30

How to improve pathways to ensure they are best for patients

  • Discuss how we ensure the most appropriate pathways are in place for patients
  • Learn how GIRFT methodology can be used to improve pathways and promotes QI solutions
  • Reflecting the impact of changing pathways on the workforce, to ensure that patient needs are met

Debra Palmer, Senior Transformation Manager, West Midlands Cancer Alliance

Dr Liz Toy, Clinical Lead Lung Cancer GIRFT

Realistically how can data ensure you help your population?

  • Is late diagnosis the reason cancer outcomes are not what they should be? Understand what the data shows us regarding variances in diagnosis, treatment and response
  • Learn what data is available across the UK and how you can use it to inform your work
  • How local and regional linked datasets can add insights to the national datasets
  • Discuss the opportunities given by data sources to affect programmes of care

Andi Orlowski, Deputy Director, Business Intelligence, Imperial College Health Partners, Senior Advisor Population Health Analytics, NHS England

James Peach, Commercial Director, DATA-CAN, the HDR UK Cancer Hub

James Warburton, Medical Director, Oncology, Novartis

14:30 – 14:35

Session change

14:35 – 15:15

Living with and beyond cancer: from diagnosis to end of life care

  • Consider the ripple effect of a cancer diagnosis – assess the impact in all areas of life
  • Improving health outcomes for patients and the system to help alleviate the financial burden on our healthcare system
  • The social costs of living with and beyond cancer – address the impact on individuals and their family
  • From heart sink moment to chronic condition – how to make sure our support systems are fit-for-purpose for long-term management

Erling Donnelly, UK Oncology Lead, Pfizer UK

Barbara Wilson, Founder and Director, Working with Cancer

Rapid Diagnostic Centres: one size fits all?

  • Hear two different approaches to rapid diagnosis in rural areas
  • Understand how the approaches meet the specific needs of the areas
  • Consider how to establish the best model of RDC for your area

Joe Mays, Lead for Prevention and Early Diagnosis, Peninsula Cancer Alliance

Amelia Randle, Clinical Director, SWAG Cancer Alliance

15:15 – 15:45

Afternoon refreshments and networking

15:45 – 16:15

Keynote presentation:
What does it mean to be a ‘cancer patient’? Stepping outside the health system

  • How to help people feel autonomous, exploring the questions we really want to ask… but are sometimes worried to!
  • Think about the difference between clinical outcomes and patient outcomes
  • Learn what practical steps you can take to refocus on the issues that really matter to those facing cancer

Laura Fulcher, Founder, Mission Remission

16:15 – 16:30

Horizon scanning: Disrupting research cycles for real world outcomes

  • Understand how research and real world outcomes are fundamentally connected in work at the University of Manchester
  • Learn what this research means for understanding clinical complexity and pathways
  • How clinical groups, commissioners and researchers can work together to improve outcomes for complex cases, including comorbidity

Professor Rob Bristow, Director of Manchester Cancer Research Centre, The University of Manchester


Panel discussion:
Horizon-scanning: What the next 12 months will hold

  • Examine the range of opportunities and solutions for the coming year, including new technology, novel treatments and national work
  • Discuss how to get to where we need to be in order to achieve national and local aims
  • Learn about the support and solutions available to enable your plans to progress

Professor Rob Bristow, Director of Manchester Cancer Research Centre, The University of Manchester

Professor Berne Ferry, Head of the National School of Healthcare Science

Steve Williamson, Lead Cancer Pharmacist, NHS England and Improvement

17:00 – 18:00

Chair’s closing remarks followed by networking reception

Ben Clover, Bureau Chief, HSJ

Click here to download the programme

By continuing to use the site you agree to our cookies policy. Accept